Evidence map›Paper›PMID 29746483›Full record

ArticlePloS one2018

Efficient detection of symptomatic and asymptomatic patient samples for Babesia microti and Borrelia burgdorferi infection by multiplex qPCR.

Shekerah Primus, Lavoisier Akoolo, Samantha Schlachter, Kristine Gedroic, Albert D Rojtman, Nikhat Parveen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Global meta-analysis onPathogens and global health · 2022
    Pooled it
  2. Long-term survival ofMicrobiology spectrum · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Life (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Protozoan ParasiteFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shekerah PrimusDepartment of Microbiology, Biochemistry and molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.
Lavoisier AkooloDepartment of Microbiology, Biochemistry and molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.
Samantha SchlachterDepartment of Microbiology, Biochemistry and molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.
Kristine GedroicThe Gedroic Center, Morristown, NJ, United States of America.
Albert D RojtmanMeridian Health, Jersey Shore University Medical Center, Neptune, NJ, United States of America.
Nikhat ParveenDepartment of Microbiology, Biochemistry and molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.ORCID 0000-0003-0592-0693
Rutgers, The State University of New Jersey · USJersey Shore University Medical Center · US

Funding

Borrelia burgdorferi-glycosaminoglycan interactions and Lyme disease pathogenesisR01AI089921 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PARVEEN, NIKHAT · 2011 to 2015
$1.7M
NIAID NIH HHS R01 AI089921NIH HHS AI089921
6 · The paper itself

Abstract

backgroundTick-borne infections have been increasing steadily over the years, with co-infections with Borrelia burgdorferi and Babesia microti/divergens emerging as a serious health problem. B. burgdorferi is a spirochetal bacterium that causes Lyme disease while protozoan pathogens belonging to Babesia species are responsible for babesiosis. Currently used serological tests do not always detect acute Lyme disease or babesiosis, and fail to differentiate cured patients from those who get re-infected. This is a major problem for proper diagnosis particularly in regions endemic for tick-borne diseases. Microscopy based evaluation of babesiosis is confirmatory but is labor intensive and insensitive such that many asymptomatic patients remain undetected and donate blood resulting in transfusion transmitted babesiosis.

resultsWe conducted multiplex qPCR for simultaneous diagnosis of active Lyme disease and babesiosis in 192 blood samples collected from a region endemic for both diseases. We document qPCR results obtained from testing of each sample three times to detect infection with each pathogen separately or together. Results for Lyme disease by qPCR were also compared with serological tests currently used for Lyme disease when available. Considering at least two out of three test results for consistency, 18.2% of patients tested positive for Lyme disease, 18.7% for co-infection with B. burgdorferi and B. microti and 6.3% showed only babesiosis.

conclusionsWith an 80% sensitivity for detection of Lyme disease, and ability to detect co-infection with B. microti, multiplex qPCR can be employed for diagnosis of these diseases to start appropriate treatment in a timely manner.

Indexed as

AnimalsBabesia microtiBabesiosisBorrelia burgdorferiCoinfectionHumansLyme DiseaseReal-Time Polymerase Chain ReactionTick-Borne DiseasesTicks

Identifiers

PMID29746483
PMCPMC5945202
OpenAlexW2800797602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.